These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4010219)

  • 1. [Philadelphia translocation and the human c-abl oncogene--relations in the light of molecular genetics].
    Bartram CR; Grosveld G
    Klin Padiatr; 1985; 197(3):196-202. PubMed ID: 4010219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
    Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
    Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region.
    ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM
    Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of oncogenes and suppressor genes in human neoplasia.
    Brodeur GM
    Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into the Philadelphia translocation.
    Heisterkamp N; Groffen J
    Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.
    de Klein A; van Kessel AG; Grosveld G; Bartram CR; Hagemeijer A; Bootsma D; Spurr NK; Heisterkamp N; Groffen J; Stephenson JR
    Nature; 1982 Dec; 300(5894):765-7. PubMed ID: 6960256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular biology of CML: a review.
    Leibowitz D; Young KS
    Cancer Invest; 1989; 7(2):195-203. PubMed ID: 2676087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.
    De Klein A; Hagemeijer A; Bartram CR; Houwen R; Hoefsloot L; Carbonell F; Chan L; Barnett M; Greaves M; Kleihauer E
    Blood; 1986 Dec; 68(6):1369-75. PubMed ID: 3465378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangement of the human ABL oncogene in a glioblastoma.
    Heisterkamp N; Morris C; Sender L; Knoppel E; Uribe L; Cui MY; Groffen J
    Cancer Res; 1990 Jun; 50(11):3429-34. PubMed ID: 2334939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the translocation breakpoint in a patient with Philadelphia positive, bcr negative acute lymphoblastic leukaemia.
    van der Feltz MJ; Shivji MK; Grosveld G; Wiedemann LM
    Oncogene; 1988 Aug; 3(2):215-9. PubMed ID: 3166123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.
    Bartram CR; de Klein A; Hagemeijer A; Grosveld G; Heisterkamp N; Groffen J
    Blood; 1984 Jan; 63(1):223-5. PubMed ID: 6336312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia.
    Morris CM; Reeve AE; Fitzgerald PH; Hollings PE; Beard ME; Heaton DC
    Nature; 1986 Mar 20-26; 320(6059):281-3. PubMed ID: 3007992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural organization of the bcr gene and its role in the Ph' translocation.
    Heisterkamp N; Stam K; Groffen J; de Klein A; Grosveld G
    Nature; 1985 Jun 27-Jul 3; 315(6022):758-61. PubMed ID: 2989703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of chronic myelogenous leukaemia.
    Ankathil R; Nair MK
    Natl Med J India; 1992; 5(5):219-22. PubMed ID: 1302582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-abl and bcr are rearranged in a Ph1-negative CML patient.
    Bartram CR; Kleihauer E; de Klein A; Grosveld G; Teyssier JR; Heisterkamp N; Groffen J
    EMBO J; 1985 Mar; 4(3):683-6. PubMed ID: 3859408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.